Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase I/II Trial of Anti-CTLA4-NF mAb (BMS-986218) in Combination With Nivolumab and Hypofractionated Stereotactic Radiation Therapy in Patients With Advanced Solid Malignancies

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04785287
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:19.168598+00:00
Published At
2026-03-03T00:00:00+00:00
Record Updated At
2026-03-03
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Advanced Lung Carcinoma", "Advanced Malignant Solid Neoplasm", "Malignant Adrenal Gland Neoplasm", "Metastatic Liver Carcinoma", "Metastatic Lung Carcinoma", "Metastatic Malignant Solid Neoplasm", "Stage III Liver Cancer", "Stage III Lung Cancer AJCC v8", "Stage IIIA Lung Cancer AJCC v8", "Stage IIIB Lung Cancer AJCC v8", "Stage IIIC Lung Cancer AJCC v8", "Stage IV Liver Cancer", "Stage IV Lung Cancer AJCC v8", "Stage IVA Liver Cancer", "Stage IVA Lung Cancer AJCC v8", "Stage IVB Liver Cancer", "Stage IVB Lung Cancer AJCC v8"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-03-03"
protocolSection.identificationModule.nctId
"NCT04785287"
protocolSection.identificationModule.officialTitle
"Phase I/II Trial of Anti-CTLA4-NF mAb (BMS-986218) in Combination With Nivolumab and Hypofractionated Stereotactic Radiation Therapy in Patients With Advanced Solid Malignancies"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Advanced Lung Carcinoma (protocolSection.conditionsModule.conditions)
  • Advanced Malignant Solid Neoplasm (protocolSection.conditionsModule.conditions)
  • Malignant Adrenal Gland Neoplasm (protocolSection.conditionsModule.conditions)
  • Metastatic Liver Carcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Lung Carcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Malignant Solid Neoplasm (protocolSection.conditionsModule.conditions)
  • Stage III Liver Cancer (protocolSection.conditionsModule.conditions)
  • Stage III Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIA Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIB Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIC Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Liver Cancer (protocolSection.conditionsModule.conditions)
  • Stage IV Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVA Liver Cancer (protocolSection.conditionsModule.conditions)
  • Stage IVA Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVB Liver Cancer (protocolSection.conditionsModule.conditions)
  • Stage IVB Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.